Page last updated: 2024-09-04

vatalanib and cgp 53716

vatalanib has been researched along with cgp 53716 in 1 studies

Compound Research Comparison

Studies
(vatalanib)
Trials
(vatalanib)
Recent Studies (post-2010)
(vatalanib)
Studies
(cgp 53716)
Trials
(cgp 53716)
Recent Studies (post-2010) (cgp 53716)
27642981502

Protein Interaction Comparison

ProteinTaxonomyvatalanib (IC50)cgp 53716 (IC50)
Tyrosine-protein kinase ABL1Homo sapiens (human)0.3981
Platelet-derived growth factor receptor betaMus musculus (house mouse)0.1
Breakpoint cluster region proteinHomo sapiens (human)0.3981
Platelet-derived growth factor receptor alpha Mus musculus (house mouse)0.1

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Campochiaro, PA; Kwak, N; Okamoto, N; Wood, JM1

Other Studies

1 other study(ies) available for vatalanib and cgp 53716

ArticleYear
VEGF is major stimulator in model of choroidal neovascularization.
    Investigative ophthalmology & visual science, 2000, Volume: 41, Issue:10

    Topics: Animals; Choroidal Neovascularization; Endothelial Growth Factors; Enzyme Inhibitors; Genistein; Lymphokines; Male; Mice; Mice, Inbred C57BL; Phosphorylation; Phthalazines; Platelet-Derived Growth Factor; Protein Kinase C; Pyridines; Pyrimidines; Receptor Protein-Tyrosine Kinases; Receptors, Growth Factor; Receptors, Platelet-Derived Growth Factor; Receptors, Vascular Endothelial Growth Factor; Signal Transduction; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors

2000